John C. Rotschafer

7.5k total citations · 2 hit papers
105 papers, 5.7k citations indexed

About

John C. Rotschafer is a scholar working on Pharmacology, Infectious Diseases and Epidemiology. According to data from OpenAlex, John C. Rotschafer has authored 105 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Pharmacology, 38 papers in Infectious Diseases and 35 papers in Epidemiology. Recurrent topics in John C. Rotschafer's work include Antibiotics Pharmacokinetics and Efficacy (72 papers), Antimicrobial Resistance in Staphylococcus (32 papers) and Antibiotic Resistance in Bacteria (31 papers). John C. Rotschafer is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (72 papers), Antimicrobial Resistance in Staphylococcus (32 papers) and Antibiotic Resistance in Bacteria (31 papers). John C. Rotschafer collaborates with scholars based in United States, Canada and United Kingdom. John C. Rotschafer's co-authors include Michael J. Rybak, Donald P. Levine, Robert C. Moellering, Ben M. Lomaestro, Marianne Billeter, J. R. Dalovisio, William A. Craig, Keith A. Rodvold, Kyle Vance‐Bryan and David R.P. Guay and has published in prestigious journals such as Clinical Infectious Diseases, The American Journal of Medicine and Journal of Clinical Microbiology.

In The Last Decade

John C. Rotschafer

105 papers receiving 5.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

2008 1.4k citations Michael J. Rybak, Ben M. Lomaestro et al. American Journal of Health-System Pharmacy profile →
Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists

2020 702 citations Michael J. Rybak, Jennifer Lê et al. American Journal of Health-System Pharmacy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John C. Rotschafer United States	31	3.4k	3.1k	1.7k	1.5k	985	105	5.7k
Ben M. Lomaestro United States	25	3.2k 0.9×	3.4k 1.1×	2.2k 1.3×	1.6k 1.1×	1.0k 1.0×	50	6.0k
Manjunath P. Pai United States	37	2.7k 0.8×	3.1k 1.0×	1.3k 0.7×	1.9k 1.3×	681 0.7×	176	6.6k
Stephen H. Zinner United States	44	2.4k 0.7×	1.2k 0.4×	1.6k 0.9×	1.8k 1.3×	1.9k 1.9×	189	6.8k
Richard Quintiliani United States	42	3.4k 1.0×	1.9k 0.6×	1.0k 0.6×	2.6k 1.8×	1.9k 1.9×	260	6.9k
Harold C. Standiford United States	35	1.6k 0.5×	1.6k 0.5×	1.2k 0.7×	1.2k 0.8×	1.4k 1.5×	92	4.5k
Michael Neely United States	38	3.4k 1.0×	2.7k 0.9×	936 0.5×	2.4k 1.6×	962 1.0×	178	6.7k
Annie Wong‐Beringer United States	31	1.5k 0.4×	2.4k 0.8×	1.3k 0.8×	1.2k 0.8×	783 0.8×	86	4.3k
Michael Barza United States	49	2.0k 0.6×	1.3k 0.4×	732 0.4×	1.5k 1.0×	1.1k 1.1×	182	7.6k
David E. Nix United States	39	2.7k 0.8×	1.4k 0.4×	564 0.3×	2.7k 1.9×	1.4k 1.5×	140	5.8k
Alasdair MacGowan United Kingdom	47	2.8k 0.8×	2.2k 0.7×	1.6k 1.0×	2.3k 1.6×	2.8k 2.8×	284	8.4k

Countries citing papers authored by John C. Rotschafer

Since Specialization

Citations

This map shows the geographic impact of John C. Rotschafer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Rotschafer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Rotschafer more than expected).

Fields of papers citing papers by John C. Rotschafer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. Rotschafer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Rotschafer. The network helps show where John C. Rotschafer may publish in the future.

Co-authorship network of co-authors of John C. Rotschafer

This figure shows the co-authorship network connecting the top 25 collaborators of John C. Rotschafer. A scholar is included among the top collaborators of John C. Rotschafer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C. Rotschafer. John C. Rotschafer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rybak, Michael J., Jennifer Lê, Thomas P. Lodise, et al.. (2020). Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. American Journal of Health-System Pharmacy. 77(11). 835–864. 702 indexed citations breakdown →

Rotschafer, John C., et al.. (2013). Polymyxins: Wisdom Does Not Always Come With Age. Clinical Infectious Diseases. 57(6). 877–883. 33 indexed citations

Rybak, Michael J., Ben M. Lomaestro, John C. Rotschafer, et al.. (2009). Therapeutic Monitoring of Vancomycin in Adults. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 29(11). 1275–1279. 319 indexed citations

Hovde, Laurie B., Dana Simonson, & John C. Rotschafer. (2007). Frequency of 1st- and 2nd-step topoisomerase mutations in Streptococcus pneumoniae following levofloxacin and moxifloxacin exposure. Diagnostic Microbiology and Infectious Disease. 60(3). 295–299. 2 indexed citations

Schafer, Jeremy A, Laurie B. Hovde, Dana Simonson, & John C. Rotschafer. (2007). In vitro pharmacodynamics of moxifloxacin versus levofloxacin against 4 strains of Streptococcus pneumoniae: 1 wild type, 2 first-step parC mutants, and 1 pump mutant. Diagnostic Microbiology and Infectious Disease. 60(2). 155–161. 2 indexed citations

Schafer, Jeremy A, et al.. (2007). Penicillin Allergy Skin Testing: What Do We Do Now?. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 27(4). 542–545. 18 indexed citations

Rotschafer, John C., et al.. (2007). Adverse events associated with the use of oral cephalosporins/cephems. Diagnostic Microbiology and Infectious Disease. 57(3). S67–S76. 19 indexed citations

Drusano, George L., et al.. (2006). Population pharmacokinetic modeling and Monte Carlo simulation of varying doses of intravenous metronidazole. Diagnostic Microbiology and Infectious Disease. 55(4). 303–309. 31 indexed citations

Hotchkiss, John R., Elizabeth D. Hermsen, Laurie B. Hovde, et al.. (2004). Dynamic Analysis of Peritoneal Dialysis Associated Peritonitis. ASAIO Journal. 50(6). 568–576. 6 indexed citations

10.

Hovde, Laurie B., Sarah E. Rotschafer, Khalid H. Ibrahim, et al.. (2003). Mutation prevention concentration of ceftriaxone, meropenem, imipenem, and ertapenem against three strains of Streptococcus pneumoniae. Diagnostic Microbiology and Infectious Disease. 45(4). 265–267. 5 indexed citations

11.

Ibrahim, Khalid H., Brent W. Gunderson, & John C. Rotschafer. (2001). Intensive care unit antimicrobial resistance and the role of the pharmacist. Critical Care Medicine. 29(Supplement). N108–N113. 28 indexed citations

12.

Gunderson, Brent W., et al.. (2001). What Do We Really Know About Antibiotic Pharmacodynamics?. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(11P2). 302S–318S. 82 indexed citations

13.

Wright, David H., et al.. (2000). Decreased In Vitro Fluoroquinolone Concentrations After Admixture With an Enteral Feeding Formulation. Journal of Parenteral and Enteral Nutrition. 24(1). 42–48. 18 indexed citations

14.

Wright, David H., et al.. (1998). Determination of quinolone antibiotics in growth media by reversed-phase high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 709(1). 97–104. 57 indexed citations

15.

Madaras‐Kelly, Karl, et al.. (1996). A pharmacodynamic evaluation of ciprofloxacin and ofloxacin against two strains of Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 37(4). 703–710. 26 indexed citations

16.

Rotschafer, John C., et al.. (1992). Selective Decontamination of the Digestive Tract in Intensive Care Patients: Review and Commentary. Annals of Pharmacotherapy. 26(7-8). 963–976. 10 indexed citations

17.

Garrison, Mark W., Darwin E. Zaske, & John C. Rotschafer. (1990). Aminoglycosides: Another Perspective. DICP. 24(3). 267–272. 18 indexed citations

18.

Garrison, Mark W., et al.. (1989). Current immunization practices. Postgraduate Medicine. 85(2). 199–210. 3 indexed citations

19.

Rodvold, Keith A., Robert A. Blum, Louise J. Riff, et al.. (1989). Simulation of Vancomycin Peak and Trough Concentrations Using Five Dosing Methods in 37 Patients. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 9(1). 10–16. 17 indexed citations

20.

Garrison, Mark W., John C. Rotschafer, & Kent Crossley. (1989). Suboptimal Effect of Daptomycin in the Treatment of Bacteremias. Southern Medical Journal. 82(11). 1414–1415. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact